Literature DB >> 9469647

Preventive effects of Hange-shashin-to on irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat.

Y Kase1, T Hayakawa, M Aburada, Y Komatsu, T Kamataki.   

Abstract

The possible preventive effect of Kampo medicine Hange-shashin-to (TJ-14) on chronic diarrheal symptoms induced by the administration of the anticancer agent irinotecan hydrochloride (CPT-11) was investigated in the rat. Repeated oral administrations of TJ-14 at 125 and 500 mg/kg significantly prevented the reduction in body weight and the onset of chronic diarrheal symptoms due to CPT-11 in a dose-dependent manner, even though it failed to show a definite effect on acute diarrheal symptoms. In addition, treatment with TJ-14 accelerated the healing of the intestinal tract injured by repeated dosing of CPT-11 and inhibited significantly the increase of colonic prostaglandin E2 (PGE2) which is closely related to the onset of diarrhea. TJ-14 also improved colonic water absorption impaired by repeated dosing of CPT-11 in rats. These results demonstrate that TJ-14 is an effective medicine for the prevention and/or treatment of CPT-11-induced chronic diarrheal symptoms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9469647     DOI: 10.1254/jjp.75.407

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  15 in total

1.  Kampo medicine "Dai-kenchu-to" prevents CPT-11-induced small-intestinal injury in rats.

Authors:  Motoya Chikakiyo; Mitsuo Shimada; Toshihiro Nakao; Jun Higashijima; Kozo Yoshikawa; Masanori Nishioka; Takashi Iwata; Nobuhiro Kurita
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Effect of Hangeshashinto on calprotectin expression in human oral epithelial cells.

Authors:  Yuka Hiroshima; Mika Bando; Yuji Inagaki; Reiko Kido; Masatoshi Kataoka; Toshihiko Nagata; Jun-Ichi Kido
Journal:  Odontology       Date:  2015-02-04       Impact factor: 2.634

Review 3.  Herb-drug interactions: a literature review.

Authors:  Zeping Hu; Xiaoxia Yang; Paul Chi Lui Ho; Sui Yung Chan; Paul Wan Sia Heng; Eli Chan; Wei Duan; Hwee Ling Koh; Shufeng Zhou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

Authors:  Umang Swami; Sanjay Goel; Sridhar Mani
Journal:  Curr Drug Targets       Date:  2013-06       Impact factor: 3.465

5.  Effects of Banxia Xiexin Decoction () on Cisplatin-Induced Apoptosis of Human A549 Lung Cancer Cells.

Authors:  Ha-Rim Kim; Guem-San Lee; Mi-Seong Kim; Do-Gon Ryu; Hong-Seob So; Hyoung-Chul Moon; Young-Rae Lee; Sei-Hoon Yang; Kang-Beom Kwon
Journal:  Chin J Integr Med       Date:  2018-01-15       Impact factor: 1.978

6.  Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects.

Authors:  W E Hardman; M P Moyer; I L Cameron
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

7.  Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.

Authors:  Chu Matsuda; Yoshinori Munemoto; Hideyuki Mishima; Naoki Nagata; Mitsuru Oshiro; Masato Kataoka; Junichi Sakamoto; Toru Aoyama; Satoshi Morita; Toru Kono
Journal:  Cancer Chemother Pharmacol       Date:  2015-05-17       Impact factor: 3.333

Review 8.  Kampo medicines for gastrointestinal tract disorders: a review of basic science and clinical evidence and their future application.

Authors:  Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

9.  Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients.

Authors:  Jun-Ichi Yamakawa; Yoshiharu Motoo; Junji Moriya; Masao Ogawa; Hiroaki Uenishi; Sumiyo Akazawa; Toshiyuki Sasagawa; Matomo Nishio; Junji Kobayashi
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-19       Impact factor: 2.629

10.  Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.

Authors:  Toru Aoyama; Kazuhiro Nishikawa; Nobuhiro Takiguchi; Kazuaki Tanabe; Motohiro Imano; Ryoji Fukushima; Junichi Sakamoto; Mari S Oba; Satoshi Morita; Toru Kono; Akira Tsuburaya
Journal:  Cancer Chemother Pharmacol       Date:  2014-03-21       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.